Alnylam About
Alnylam Alnylam Pharmaceuticals, Inc. (Alnylam) is an
early stage, biopharmaceutical company seeking to develop and commercialize therapeutics
based on a biological pathway, RNA
interference (RNAi). RNA interference is a natural mechanism for selective
silencing of specific genes. Age-related Macular Degeneration (AMD) Respiratory
Syncytial Virus (RSV) Spinal Cord Injury (SCI) Parkinson's Disease
(PD) More
on Alnylam
Key
Statistics for Alnyam
Basic
Chart for Alnylam